logo
Select company
Select metric
$ 64.19MShareholders Equity
VS
Market
31
Sector
49
Industry
53
History
100
$ 7.33Close
$ 3.43 - $ 14.41 52-Week Range
Ticker Information

Ticker

NAGE

Company Name

NIAGEN BIOSCIENCE INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NIAGEN BIOSCIENCE INC - Shareholders Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NAGE - Equity Historical data
DateShareholders Equity
6/30/2025$ 64.19M
3/31/2025$ 55.34M
12/31/2024$ 46.09M
9/30/2024$ 34.37M
6/30/2024$ 30.72M
3/31/2024$ 28.95M
12/31/2023$ 28.46M
9/30/2023$ 27.31M
6/30/2023$ 27.15M
3/31/2023$ 28.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NIAGEN BIOSCIENCE INC's latest trailing twelve months (TTM) Equity stands at $ 19.49M.
  • Over the past 5 years, NIAGEN BIOSCIENCE INC's average Equity has been $ 32.8M.
  • The median Equity for NIAGEN BIOSCIENCE INC during this period was $ 28.81M
  • NIAGEN BIOSCIENCE INC reached its highest Equity over the past 5 years at $ 64.19M.
  • The lowest Equity recorded by NIAGEN BIOSCIENCE INC in the same timeframe $ 16.42M

NIAGEN BIOSCIENCE INC's Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Equity Benchmarks
CompanyEquity
CRMD : CORMEDIX INC $ 220.63MPHAT : PHATHOM PHARMACEUTICALS INC $ -405.83MGYRE : GYRE THERAPEUTICS INC $ 92.03MANAB : ANAPTYSBIO INC $ -44.73MZYME : ZYMEWORKS INC $ 334.51MURGN : UROGEN PHARMA LTD $ -93.38MNRIX : NURIX THERAPEUTICS INC $ 372.25MTBPH : THERAVANCE BIOPHARMA INC $ 224.85MSNDX : SYNDAX PHARMACEUTICALS INC $ 157.42MXNCR : XENCOR INC $ 620.35M

Definition of Shareholders Equity

[Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.

NAGE - Shareholders Equity, Last 5 years

$ 16.42M

Minimum

Dec 31, 2020

$ 64.19M

Maximum

Jun 30, 2025

$ 32.8M

Average

$ 28.81M

Median

Equity Benchmark Analysis

The chart above depicts the distribution of Equity for companies in the Total Stock Market. The average Equity of the companies is $ 384M with a standard deviation of $ 548.41M.
The following table provides additional summary stats:
Equity in the Market:
filtered constituents3.47K
min$ -1.4B
max$ 2.14B
average$ 384M
median$ 165.72M
std$ 548.41M